Pharmaxis Ltd Health Care
Biotech Cancer Healthcare Pharmaceuticals

$0.049 0.007 (16.67%)

High $0.05	Low $0.04	Trades 74	Turnover $48,318	Volume 1,094,468
30 June 2023 at 4:10pm

Market Cap (9-Feb) $19,510,578 (1,113th)	Close (30-Jun) $0.049 0 (0%)	Volume (30-Jun) 1,094,468	Shortsold (12-Jul) 1 (0.00%) (672nd)
52w High $0.000	52w Low $0.000	P/E 20.45	EPS -0.02
ASX Announcements (7d) -	Twitter Mentions (7d) 0+	AFR Articles (7d) 1	News Articles (7d) 1+

Short Interest

ASIC data, 12 Jul 2023

% Shorted

0.00%

vs 0.00% prior report

Most Shorted Rank

672nd

of 697 shorted ASX stocks

Peak Short

4.88%

Apr 2013

Days to Cover

0.0

at 50d avg vol

View full short position history →

	Subject
	PXS PXS Ann: Investor presentation
	1 (current) 2 3
	PXS PXS Ann: PXS Announces Encouraging Results from Phase 1c Scar Study
	PXS PXS Ann: Trading Halt
	PXS PXS Ann: Investor Presentation - Quarterly Briefing
	PXS PXS Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	PXS PXS Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	PXS PXS Ann: PXS Quarterly Update and Investor Briefing
	PXS PXS Ann: After FDA Review PXS Accelerates Plans for Combination Study
	PXS PXS Ann: Ceasing to be a substantial holder
	PXS PXS Ann: Pharmaxis Drug Study Published in Nature Communications
	PXS PXS Ann: Becoming a substantial holder
	PXS PXS Ann: Change in substantial holding
	PXS PXS Ann: Application for quotation of securities - PXS
	PXS PXS Ann: Application for quotation of securities - PXS
	PXS PXS Ann: Change in substantial holding
	PXS PXS Ann: PXS Securities Trading Policy - Updated 10 Feb 2023
	PXS PXS Ann: Half Yearly Report and Accounts
	PXS PXS Ann: Investor Presentation
	PXS PXS Ann: Investor Presentation
	PXS PXS Ann: Quarterly Activities Report
	PXS PXS Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	PXS PXS Ann: Quarterly Shareholder Update and Investor Briefing
	PXS PXS Ann: Application for quotation of securities - PXS
	PXS PXS Ann: Initial Director's Interest Notice
	PXS PXS Ann: Director Appointment/Resignation
	PXS PXS Ann: Pharmaxis Receives $5m R&D Tax Incentive
	PXS PXS Ann: Application for quotation of securities - PXS
	PXS PXS Ann: Pharmaxis Skin Scarring Study Fully Recruited
	PXS PXS Ann: Initial Director's Interest Notice
	PXS PXS Ann: Pharmaxis Appoints Dr Simon Green as Director
	PXS PXS Ann: Change in substantial holding
	PXS PXS Ann: PXS Drug Profiled American Society of Hematology Conference
	PXS PXS Ann: Application for quotation of securities - PXS
	PXS PXS Ann: Change in substantial holding
	PXS PXS Ann: Becoming a substantial holder
	PXS PXS Ann: Change in substantial holding
	PXS PXS Ann: Section 708(5)(e) Notice
	PXS PXS Ann: Ceasing to be a substantial holder
	PXS PXS Ann: Change of Director's Interest Notice
	PXS PXS Ann: Change of Director's Interest Notice
	PXS PXS Ann: Change of Director's Interest Notice
	PXS PXS Ann: Notification regarding unquoted securities - PXS
	PXS PXS Ann: Application for quotation of securities - PXS
	PXS PXS Ann: Change of Director's Interest Notice
	PXS PXS Ann: Notification regarding unquoted securities - PXS
	PXS PXS Ann: Results of Meeting
	PXS PXS Ann: Chairman's Address to Shareholders
	PXS PXS Ann: CEO Presentation to 2022 AGM
	PXS PXS Ann: Application for quotation of securities - PXS
	PXS PXS Ann: Investor Presentation

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Mayne Pharma Group

MYX

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Recce Pharmaceuticals Ltd

RCE

Starpharma Holdings

SPL

End of Day Prices

Date	Close	Volume	Change
08-Feb	$0.02	2,313,063	0.00 (0.00%)
07-Feb	$0.02	88,549	0.00 (0.00%)
06-Feb	$0.02	185,399	0.00 (0.00%)
05-Feb	$0.02	527,551	0.00 (0.00%)
02-Feb	$0.02	762,847	+0.00 (5.00%)
01-Feb	$0.02	1,829,174	+0.00 (5.26%)
31-Jan	$0.02	3,202,962	0.00 (0.00%)
30-Jan	$0.02	1,188,895	+0.00 (11.76%)
29-Jan	$0.02	637,140	0.00 (0.00%)
25-Jan	$0.02	788,861	0.00 (0.00%)
24-Jan	$0.02	881,505	0.00 (5.56%)
23-Jan	$0.02	636,016	+0.00 (5.88%)
22-Jan	$0.02	78,661,135	0.00 (0.00%)
19-Jan	$0.02	52,375	0.00 (0.00%)
18-Jan	$0.02	1,295,388	0.00 (10.53%)
4 up, 2 down, and 9 flat days

Pharmaxis Ltd Health Care Biotech Cancer Healthcare Pharmaceuticals

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Pharmaxis Ltd Health Care
Biotech Cancer Healthcare Pharmaceuticals